A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome
Peter E. Morris, Peter Papadakos, James A. Russell, Richard Wunderink, Daniel P. Schuster, Jonathon D. Truwit, Jean Louis Vincent, Gordon R. Bernard
Dive into the research topics of 'A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome'. Together they form a unique fingerprint.